Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial apical junctional complex (AJC) is a highly specialized structure located at the boundary between the apical and lateral plasma membranes of enterocytes, consisting of the tight junction (TJ) and the adherens junction (AJ) (PubMed: 28414303). The TJ is the most apical component and acts as a primary gatekeeper, regulating the paracellular movement of water, ions, and small molecules through proteins like claudins, occludin, and zonula occludens (ZO) proteins (NIH: NBK547711). Directly below the TJ, the AJ provides the mechanical adhesive force necessary to hold cells together and serves as a hub for intracellular signaling via E-cadherin and catenin proteins (PubMed: 25324231). Maintaining the integrity of the AJC is essential for intestinal homeostasis, as its breakdown leads to increased permeability, allowing pathogens and toxins to trigger systemic immune responses (PubMed: 31076401). This complex is a significant therapeutic target in conditions like celiac disease and inflammatory bowel disease, where drugs like larazotide acetate are used to prevent junctional disassembly (PubMed: 26075968). Other agents, such as lubiprostone, enhance barrier repair by promoting the assembly of these junctional proteins through chloride channel activation (PubMed: 21248765). Therapeutic strategies also include the use of GLP-2 analogs like teduglutide, which stimulate epithelial growth and junctional integrity (PubMed: 24681584).
Regulation of paracellular permeability through the stabilization of transmembrane proteins like claudins and occludin, often via zonulin antagonism or activation of chloride channels to promote junctional assembly.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial apical junctional complex (AJC) (AJC).